Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Panel finds efficacy for Regeneron’s REGEN-COV in Phase III Covid-19 trial

pharmaceutical-technologyMarch 01, 2021

Tag: REGEN-COV , Regeneron , IDMC , COVID-19

PharmaSources Customer Service